首页 > 最新文献

University Heart Journal最新文献

英文 中文
Familiar form of ASD with Mitral Stenosis – An Uncommon Presentation of Lutembacher’s Syndrome 伴有二尖瓣狭窄的熟悉型 ASD--卢滕巴赫综合征的一种不常见表现形式
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73755
Afm Azim Anwar, Sanjida Anjum Mumu, Md Noornabi Khondokar, Md Tafijul Islam, Md Azharul Islam, Manzoor Mahmood, Md. Fakhrul Islam Khaled
Lutembacher’s syndrome refers to combination of congenital Atrial Septal Defect with acquired mitral stenosis. Lutembacher’s syndrome is a vety rare disease and in the past, it has been either over diagnosed or misdiagnosed. Here, we will discuss the case of a lady who presented with chief complaints of palpitation and dyspnea and after detailed examination and investigations; she was diagnosed as a case of “Lutembacher’s syndrome”. University Heart Journal 2023; 19(2): 66-70
卢滕巴赫综合征是指先天性心房间隔缺损与后天性二尖瓣狭窄的合并症。卢滕巴赫氏综合征是一种非常罕见的疾病,过去曾被过度诊断或误诊。在此,我们将讨论一位以心悸和呼吸困难为主诉的女士的病例,经过详细检查和研究,她被诊断为 "卢滕巴赫综合征"。大学心脏杂志,2023;19(2):66-70
{"title":"Familiar form of ASD with Mitral Stenosis – An Uncommon Presentation of Lutembacher’s Syndrome","authors":"Afm Azim Anwar, Sanjida Anjum Mumu, Md Noornabi Khondokar, Md Tafijul Islam, Md Azharul Islam, Manzoor Mahmood, Md. Fakhrul Islam Khaled","doi":"10.3329/uhj.v3i1.73755","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73755","url":null,"abstract":"Lutembacher’s syndrome refers to combination of congenital Atrial Septal Defect with acquired mitral stenosis. Lutembacher’s syndrome is a vety rare disease and in the past, it has been either over diagnosed or misdiagnosed. Here, we will discuss the case of a lady who presented with chief complaints of palpitation and dyspnea and after detailed examination and investigations; she was diagnosed as a case of “Lutembacher’s syndrome”. \u0000University Heart Journal 2023; 19(2): 66-70","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"116 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141657519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between the GRACE Risk Score and the SYNTAX Score in Patients with Non-ST-Segment Elevation Myocardial Infarction 非 ST 段抬高型心肌梗死患者的 GRACE 风险评分与 SYNTAX 评分之间的相关性
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73749
S. N. Huda, Mohammad Faisal, Ibn Kabir, MD. Tasnim MOSTASHIRUL HAQUE, Afm Azim Alam, Swadesh Kumar Anwar, SK SAHA, MD Nafis Kabir, MD. Fakrul H.N. ASHIQUR RAHMAN, Islam Khaled, Chaudhury TANJIMA PARVIN, MD. Rasul MESHKAT AHMED, Amin
Background: The GRACE risk score is a valid clinical tool to risk stratify patients with non-ST-segment elevation myocardial infarction (NSTEMI). The SYNTAX score is a comprehensive angiographic grading tool to determine the anatomic complexity of coronary artery disease. Predicting the SYNTAX score before a coronary angiogram (CAG) can help with patient counseling, optimization of planning, and preparation for possible complex percutaneous procedures or CABG in patients with NSTEMI.Objective: The objective of this study is to determine the correlation between the GRACE risk score and the SYNTAX score in patients with NSTEMI.Materials and Methods: A total of 52 patients with NSTEMI undergoing coronary angiography were enrolled in this study. According to the calculated GRACE score on admission, patients were divided into a low-risk group (GRACE score ≤108), an intermediate-risk group (GRACE score = 109–140), and a high-risk group(GRACE score > 140). After coronary angiography, the SYNTAX score was calculated. The correlation between the scores was determined by Pearson’s correlation test.Results: The mean SYNTAX score in the low GRACE risk group was 9.5 ± 5.1, in the intermediate GRACE risk group it was 12.5 ± 7.6, and in the high GRACE risk group it was 18.5 ± 8.9, and the differences were significant (P value = 0.005). There was a significant positive correlation (r = 0.515, p = <0.001) between the GRACE risk score and the SYNTAX score in patients with NSTEMI.Conclusion: Our study demonstrates that in NSTEMI patients, the GRACE risk score has a significant positive correlation with the SYNTAX score.University Heart Journal 2023; 19(2): 49-54
背景:GRACE 风险评分是对非 ST 段抬高型心肌梗死(NSTEMI)患者进行风险分层的有效临床工具。SYNTAX 评分是一种全面的血管造影分级工具,用于确定冠状动脉疾病的解剖复杂性。在冠状动脉造影(CAG)前预测 SYNTAX 评分有助于为 NSTEMI 患者提供患者咨询、优化计划并为可能的复杂经皮手术或 CABG 做好准备:本研究旨在确定 GRACE 风险评分与 SYNTAX 评分在 NSTEMI 患者中的相关性:本研究共纳入52名接受冠状动脉造影术的NSTEMI患者。根据入院时计算出的 GRACE 评分,患者被分为低危组(GRACE 评分 ≤108)、中危组(GRACE 评分 = 109-140)和高危组(GRACE 评分 > 140)。冠状动脉造影后,计算 SYNTAX 评分。得分之间的相关性通过皮尔逊相关检验确定:低GRACE风险组的平均SYNTAX评分为(9.5 ± 5.1)分,中GRACE风险组为(12.5 ± 7.6)分,高GRACE风险组为(18.5 ± 8.9)分,差异显著(P值= 0.005)。在NSTEMI患者中,GRACE风险评分与SYNTAX评分之间存在明显的正相关性(r = 0.515,P = <0.001):我们的研究表明,在NSTEMI患者中,GRACE风险评分与SYNTAX评分呈显著正相关:49-54
{"title":"Correlation between the GRACE Risk Score and the SYNTAX Score in Patients with Non-ST-Segment Elevation Myocardial Infarction","authors":"S. N. Huda, Mohammad Faisal, Ibn Kabir, MD. Tasnim MOSTASHIRUL HAQUE, Afm Azim Alam, Swadesh Kumar Anwar, SK SAHA, MD Nafis Kabir, MD. Fakrul H.N. ASHIQUR RAHMAN, Islam Khaled, Chaudhury TANJIMA PARVIN, MD. Rasul MESHKAT AHMED, Amin","doi":"10.3329/uhj.v3i1.73749","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73749","url":null,"abstract":"Background: The GRACE risk score is a valid clinical tool to risk stratify patients with non-ST-segment elevation myocardial infarction (NSTEMI). The SYNTAX score is a comprehensive angiographic grading tool to determine the anatomic complexity of coronary artery disease. Predicting the SYNTAX score before a coronary angiogram (CAG) can help with patient counseling, optimization of planning, and preparation for possible complex percutaneous procedures or CABG in patients with NSTEMI.\u0000Objective: The objective of this study is to determine the correlation between the GRACE risk score and the SYNTAX score in patients with NSTEMI.\u0000Materials and Methods: A total of 52 patients with NSTEMI undergoing coronary angiography were enrolled in this study. According to the calculated GRACE score on admission, patients were divided into a low-risk group (GRACE score ≤108), an intermediate-risk group (GRACE score = 109–140), and a high-risk group\u0000(GRACE score > 140). After coronary angiography, the SYNTAX score was calculated. The correlation between the scores was determined by Pearson’s correlation test.\u0000Results: The mean SYNTAX score in the low GRACE risk group was 9.5 ± 5.1, in the intermediate GRACE risk group it was 12.5 ± 7.6, and in the high GRACE risk group it was 18.5 ± 8.9, and the differences were significant (P value = 0.005). There was a significant positive correlation (r = 0.515, p = <0.001) between the GRACE risk score and the SYNTAX score in patients with NSTEMI.\u0000Conclusion: Our study demonstrates that in NSTEMI patients, the GRACE risk score has a significant positive correlation with the SYNTAX score.\u0000University Heart Journal 2023; 19(2): 49-54","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"124 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141656835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitral annular Calcification and Cardiovascular mortality 二尖瓣环钙化与心血管死亡率
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73754
Mohammad Ashraf Uddin Sultan, H. Hoque, Khurshed Ahmed, M. M. Rahman, Atm Iqbal Hasan, Md Abu Salim, Naveen Sheikh, C. M. Ahmed, N. Fatema
Mitral annular calcification (MAC) is a degenerative change involving mitral valve annulus which has an increased cardiovascular mortality and morbidity. After first autoptic description, a diagnostic tool brought cardiac computed tomography (CT) scan to become the gold standard in MAC detection and classification. The Mitral annular calcifications has always represented an issue for cardiac surgeons, being it linked with an increased risk of atrioventricular groove rupture, circumflex artery injury, or embolism during Mitral valve surgery. As a consequence, different surgical techniques have been developed over time in order to reduce the incidence of these dreadful complications. Recently, transcatheter mitral valve replacement (TMVR) has emerged as a valid alternative to surgery in high-risk patients on the basis of TAVR. Both hybrid transatrial, transfemoral, or transapical approaches have been described to deliver balloon-expandable or self-expanding aortic transcatheter valves into the calcified annulus, with conflicting early and long-term results. Tendyne (Abbott Structural Heart, Santa Clara, CA, USA) is a promising transapical-delivered option. Early results have shown effectiveness and safety of this device in patients with MAC and severe mitral valve disease, with the lowest rate of embolization, mortality, and left ventricular outflow tract obstruction (LVOTO) reported so far.University Heart Journal 2023; 19(2): 61-65
二尖瓣环钙化(MAC)是一种涉及二尖瓣环的退行性病变,会增加心血管疾病的死亡率和发病率。二尖瓣瓣环钙化是二尖瓣瓣环的退行性病变,会增加心血管疾病的死亡率和发病率。在首次自动光学描述之后,一种诊断工具使心脏计算机断层扫描(CT)成为二尖瓣瓣环钙化检测和分类的金标准。二尖瓣环钙化一直是心脏外科医生面临的一个问题,因为它与二尖瓣手术中房室沟破裂、环状动脉损伤或栓塞的风险增加有关。因此,为了降低这些可怕并发症的发生率,不同的手术技术应运而生。最近,在 TAVR 的基础上,经导管二尖瓣置换术(TMVR)成为高危患者手术的有效替代方案。经房、经口或经心尖的混合方法都被描述为将球囊扩张或自扩张的主动脉经导管瓣膜置入钙化的瓣环,但早期和长期的结果却不尽相同。Tendyne(雅培结构性心脏公司,美国加利福尼亚州圣克拉拉)是一种很有前景的经心尖置入选择。早期结果显示,该装置对患有 MAC 和严重二尖瓣疾病的患者有效且安全,栓塞率、死亡率和左室流出道梗阻(LVOTO)是迄今为止报道的最低的:61-65
{"title":"Mitral annular Calcification and Cardiovascular mortality","authors":"Mohammad Ashraf Uddin Sultan, H. Hoque, Khurshed Ahmed, M. M. Rahman, Atm Iqbal Hasan, Md Abu Salim, Naveen Sheikh, C. M. Ahmed, N. Fatema","doi":"10.3329/uhj.v3i1.73754","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73754","url":null,"abstract":"Mitral annular calcification (MAC) is a degenerative change involving mitral valve annulus which has an increased cardiovascular mortality and morbidity. After first autoptic description, a diagnostic tool brought cardiac computed tomography (CT) scan to become the gold standard in MAC detection and classification. The Mitral annular calcifications has always represented an issue for cardiac surgeons, being it linked with an increased risk of atrioventricular groove rupture, circumflex artery injury, or embolism during Mitral valve surgery. As a consequence, different surgical techniques have been developed over time in order to reduce the incidence of these dreadful complications. Recently, transcatheter mitral valve replacement (TMVR) has emerged as a valid alternative to surgery in high-risk patients on the basis of TAVR. Both hybrid transatrial, transfemoral, or transapical approaches have been described to deliver balloon-expandable or self-expanding aortic transcatheter valves into the calcified annulus, with conflicting early and long-term results. Tendyne (Abbott Structural Heart, Santa Clara, CA, USA) is a promising transapical-delivered option. Early results have shown effectiveness and safety of this device in patients with MAC and severe mitral valve disease, with the lowest rate of embolization, mortality, and left ventricular outflow tract obstruction (LVOTO) reported so far.\u0000University Heart Journal 2023; 19(2): 61-65","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"33 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141658793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Echocardiographic profile of NSTEMI patients, before and after PCI in Diabetes vs. Non-Diabetes group 糖尿病组和非糖尿病组 NSTEMI 患者 PCI 前后超声心动图特征的变化
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73742
Afm Azim Anwar, Sanjida Anjum Mumu, Md Yousuf Ali, Srizon Roy Tirtho, Adib Siddik, M. Chowdhury, Md. Fakhrul Islam Khaled, Smg Saklayen, H. Hoque
Background: Revascularization may improve outcomes of patients with LV dysfunction by improvement of EF. Though this is not so, in diabetic patients. Because diabetic ischemic etiology is consistently reported as a risk factor for lack of ejection fraction (EF) improvement after revascularization. The determinants of EF improvement havenot yet been investigated comprehensively among diabetic vs nondiabetic group. The goal of the study was to examine how diabetic and non-diabetic patients’ left ventricular systolic performance change from the beginning of the trial to three months following PCI. Methodology: This comparative clinical study, conducted at Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, from January to December 2018 with IRB clearance (Protocol No: BSMMU/2017/ 6624), adhered to Helsinki declaration principles. Patient selection based on inclusion/exclusion criteria involved comprehensive history-taking and clinical examinations. Transthoracic 2D echocardiography was performed pre-PCI, at discharge, and 3 months post-PCI using validated measurements. Left ventricular function parameters were assessed, and coronary angiography preceded percutaneous coronary intervention (PCI) with newer drug-eluting stents. Standard procedural techniques and anticoagulation were employed, maintaining medication consistency to minimize confounding variables. Results: In our study, diabetic patients significantly improved systolic function, after PCI, to the point where it was nearly comparable to non-diabetes. Most of these measures were poorer in diabetics than in nondiabetics at baseline. However, in this subgroup, our study also demonstrated excellent reversibility of these negative effects following PCI. After PCI, there was also a change in LVEF in non-diabetics. Both people with diabetes and people without diabetes showed improvement in WMA. However, the degree of improvement in these two groups varied. Discussion: This study compared coronary stenosis in diabetic and non-diabetic patients. Diabetics exhibited significantly higher LAD stenosis (60% vs. 40%), while RCA and LCx stenoses were similar. Baseline LVEF, LVESV, and LVIDs showed no significant differences between groups. Diabetics had more regional wall motion abnormalities. Three months post-PCI, both groups improved in LV parameters, with no significant inter-group differences. Diabetic patients showed improved LVEF, contrary to a study by Nabati et al. in non-diabetics. Regional wall motion abnormalities decreased more in non-diabetic patients Conclusion: Contrary to the common belief favoring CABG for diabetics, our study indicates that newer drug-eluting stents offer comparable benefits in clinical outcomes, survival rates, and LV systolic function improvements for both diabetic and non-diabetic patients. University Heart Journal 2023; 19(2): 45-48
背景:血管重建可通过改善 EF 改善左心室功能障碍患者的预后。但糖尿病患者的情况并非如此。据报道,糖尿病缺血性病因一直是血管再通术后射血分数(EF)无法改善的风险因素。目前尚未对糖尿病组和非糖尿病组患者射血分数改善的决定因素进行全面研究。本研究的目的是探讨糖尿病患者和非糖尿病患者的左心室收缩功能从试验开始到PCI术后三个月的变化情况。研究方法:这项比较临床研究于2018年1月至12月在孟加拉国达卡的班加班杜-谢赫-穆吉布医科大学(Bangabandhu Sheikh Mujib Medical University)进行,获得了IRB批准(协议号:BSMMU/2017/ 6624),遵守赫尔辛基宣言原则。根据纳入/排除标准选择患者,包括全面的病史采集和临床检查。在PCI前、出院时和PCI后3个月,使用经验证的测量方法进行经胸二维超声心动图检查。评估了左心室功能参数,并在使用新型药物洗脱支架进行经皮冠状动脉介入治疗(PCI)前进行了冠状动脉造影。采用标准手术技术和抗凝治疗,保持用药一致性,以尽量减少混杂变量。研究结果在我们的研究中,糖尿病患者在PCI术后收缩功能明显改善,几乎与非糖尿病患者相当。在基线时,糖尿病患者的大多数指标都比非糖尿病患者差。不过,在这一亚组中,我们的研究也证明,PCI 后这些负面影响具有极佳的可逆性。PCI后,非糖尿病患者的LVEF也发生了变化。糖尿病患者和非糖尿病患者的 WMA 均有改善。不过,这两组患者的改善程度各不相同。讨论:本研究比较了糖尿病患者和非糖尿病患者的冠状动脉狭窄情况。糖尿病患者的 LAD 狭窄程度明显更高(60% 对 40%),而 RCA 和 LCx 狭窄程度相似。基线 LVEF、LVESV 和 LVID 在组间无明显差异。糖尿病患者有更多的区域室壁运动异常。PCI术后三个月,两组患者的左心室参数均有所改善,组间无明显差异。糖尿病患者的 LVEF 有所改善,这与 Nabati 等人对非糖尿病患者的研究相反。非糖尿病患者的区域室壁运动异常减少得更多 结论:我们的研究表明,较新的药物洗脱支架在临床疗效、存活率和左心室收缩功能改善方面对糖尿病患者和非糖尿病患者都有类似的益处,这与人们倾向于对糖尿病患者进行 CABG 的普遍看法相反。大学心脏杂志 2023; 19(2):45-48
{"title":"Changes in Echocardiographic profile of NSTEMI patients, before and after PCI in Diabetes vs. Non-Diabetes group","authors":"Afm Azim Anwar, Sanjida Anjum Mumu, Md Yousuf Ali, Srizon Roy Tirtho, Adib Siddik, M. Chowdhury, Md. Fakhrul Islam Khaled, Smg Saklayen, H. Hoque","doi":"10.3329/uhj.v3i1.73742","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73742","url":null,"abstract":"Background: Revascularization may improve outcomes of patients with LV dysfunction by improvement of EF. Though this is not so, in diabetic patients. Because diabetic ischemic etiology is consistently reported as a risk factor for lack of ejection fraction (EF) improvement after revascularization. The determinants of EF improvement havenot yet been investigated comprehensively among diabetic vs nondiabetic group. The goal of the study was to examine how diabetic and non-diabetic patients’ left ventricular systolic performance change from the beginning of the trial to three months following PCI. Methodology: This comparative clinical study, conducted at Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, from January to December 2018 with IRB clearance (Protocol No: BSMMU/2017/ 6624), adhered to Helsinki declaration principles. Patient selection based on inclusion/exclusion criteria involved comprehensive history-taking and clinical examinations. Transthoracic 2D echocardiography was performed pre-PCI, at discharge, and 3 months post-PCI using validated measurements. Left ventricular function parameters were assessed, and coronary angiography preceded percutaneous coronary intervention (PCI) with newer drug-eluting stents. Standard procedural techniques and anticoagulation were employed, maintaining medication consistency to minimize confounding variables. Results: In our study, diabetic patients significantly improved systolic function, after PCI, to the point where it was nearly comparable to non-diabetes. Most of these measures were poorer in diabetics than in nondiabetics at baseline. However, in this subgroup, our study also demonstrated excellent reversibility of these negative effects following PCI. After PCI, there was also a change in LVEF in non-diabetics. Both people with diabetes and people without diabetes showed improvement in WMA. However, the degree of improvement in these two groups varied. Discussion: This study compared coronary stenosis in diabetic and non-diabetic patients. Diabetics exhibited significantly higher LAD stenosis (60% vs. 40%), while RCA and LCx stenoses were similar. Baseline LVEF, LVESV, and LVIDs showed no significant differences between groups. Diabetics had more regional wall motion abnormalities. Three months post-PCI, both groups improved in LV parameters, with no significant inter-group differences. Diabetic patients showed improved LVEF, contrary to a study by Nabati et al. in non-diabetics. Regional wall motion abnormalities decreased more in non-diabetic patients Conclusion: Contrary to the common belief favoring CABG for diabetics, our study indicates that newer drug-eluting stents offer comparable benefits in clinical outcomes, survival rates, and LV systolic function improvements for both diabetic and non-diabetic patients. \u0000University Heart Journal 2023; 19(2): 45-48","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"107 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141657207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Awareness on MINOCA 提高对中非海事组织的认识
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73693
J. Arzu, C. M. Ahmed
Abstract not availableUniversity Heart Journal 2023; 19(2): 35
摘要不详《大学心脏杂志》2023;19(2):35
{"title":"Awareness on MINOCA","authors":"J. Arzu, C. M. Ahmed","doi":"10.3329/uhj.v3i1.73693","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73693","url":null,"abstract":"Abstract not available\u0000University Heart Journal 2023; 19(2): 35","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"18 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141655920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The outcome of Autogenous Venous Graft Vs Prosthetic Graft in Peripheral Arterial Disease- Study in Bangladesh 外周动脉疾病中自体静脉移植与人工血管移植的疗效--孟加拉国的研究
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73744
Mainul Mahmud, Nur A Al Amin, Kamal Hossain, Uzzal Ahmed, Ashik Rahman Rifat, Rakibul Hasan, Md Saif Ullah Khan
Graft insertion is a surgical intervention employed to address advanced stages of peripheral artery disease (PAD) or peripheral vascular disease (PVD). Peripheral artery disease (PAD) or peripheral vascular disease (PVD) refers to the narrowing or blockage of blood vessels, typically in the lower extremities resulting from the accumulation of fatty deposits (atherosclerosis). This condition leads to diminished blood flow to the affected regions. These symptoms may include leg pain, cramping, numbness, and, in severe instances, tissue damage and gangrene. Objective: This study aims to evaluate the surgical outcome of autogenous venous grafts and prosthetic grafts in peripheral arterial disease. Method: The cross-sectional study was conducted at Department of Vascular Surgery, Bangabandhu Sheikh Mujib Medical University & Enam Medical College Hospital, Savar, Dhaka - over two year from January 2021 to December 2022. This study represented patients who received surgical treatment for peripheral artery disorders using grafts, which could be either autogenous (vein) or prosthetic in nature. Results: Smoking, hypertension, and dyslipidemia were the main risk factors for PAD. The main indications of revascularization in our investigation were gangrene, critical limb ischemia, and limb salvage. In the case of a prosthetic graft, post-operative infection was higher. The other postoperative problems were thrombosisrelated occlusion and hemorrhage. Conclusion: Autogenous venous and prosthetic grafts can provide a bypass or supply blood flow to the damaged area during peripheral arterial disease (PAD) revascularization. The surgeon’s preference and the patient’s condition determine which graft type is used. In this study, prosthetic and autogenous venous grafts in PAD are compared. University Heart Journal 2023; 19(2): 55-60
移植物植入术是一种外科干预措施,用于治疗晚期外周动脉疾病(PAD)或外周血管疾病(PVD)。外周动脉疾病(PAD)或外周血管疾病(PVD)是指由于脂肪沉积(动脉粥样硬化)而导致的血管狭窄或阻塞,通常发生在下肢。这种情况会导致受影响区域的血流量减少。这些症状可能包括腿痛、抽筋、麻木,严重时还会导致组织损伤和坏疽。研究目的本研究旨在评估外周动脉疾病中自体静脉移植和人工血管移植的手术效果。研究方法这项横断面研究于 2021 年 1 月至 2022 年 12 月在达卡萨瓦尔的班加班杜谢赫-穆吉布医科大学和埃纳姆医学院附属医院血管外科进行,历时两年。这项研究的对象是接受外科手术治疗的外周动脉疾病患者,使用的移植物可以是自体(静脉)移植物,也可以是人工移植物。研究结果吸烟、高血压和血脂异常是 PAD 的主要风险因素。在我们的调查中,血管重建的主要适应症是坏疽、严重肢体缺血和肢体挽救。在假体移植的情况下,术后感染率较高。其他术后问题是血栓相关性闭塞和出血。结论在外周动脉疾病(PAD)血管再通术中,自体静脉移植物和人工血管移植物可为受损部位提供旁路或血流供应。外科医生的偏好和患者的病情决定了使用哪种移植物。本研究对PAD中的人工静脉移植物和自体静脉移植物进行了比较。大学心脏杂志 2023; 19(2):55-60
{"title":"The outcome of Autogenous Venous Graft Vs Prosthetic Graft in Peripheral Arterial Disease- Study in Bangladesh","authors":"Mainul Mahmud, Nur A Al Amin, Kamal Hossain, Uzzal Ahmed, Ashik Rahman Rifat, Rakibul Hasan, Md Saif Ullah Khan","doi":"10.3329/uhj.v3i1.73744","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73744","url":null,"abstract":"Graft insertion is a surgical intervention employed to address advanced stages of peripheral artery disease (PAD) or peripheral vascular disease (PVD). Peripheral artery disease (PAD) or peripheral vascular disease (PVD) refers to the narrowing or blockage of blood vessels, typically in the lower extremities resulting from the accumulation of fatty deposits (atherosclerosis). This condition leads to diminished blood flow to the affected regions. These symptoms may include leg pain, cramping, numbness, and, in severe instances, tissue damage and gangrene. Objective: This study aims to evaluate the surgical outcome of autogenous venous grafts and prosthetic grafts in peripheral arterial disease. Method: The cross-sectional study was conducted at Department of Vascular Surgery, Bangabandhu Sheikh Mujib Medical University & Enam Medical College Hospital, Savar, Dhaka - over two year from January 2021 to December 2022. This study represented patients who received surgical treatment for peripheral artery disorders using grafts, which could be either autogenous (vein) or prosthetic in nature. Results: Smoking, hypertension, and dyslipidemia were the main risk factors for PAD. The main indications of revascularization in our investigation were gangrene, critical limb ischemia, and limb salvage. In the case of a prosthetic graft, post-operative infection was higher. The other postoperative problems were thrombosisrelated occlusion and hemorrhage. Conclusion: Autogenous venous and prosthetic grafts can provide a bypass or supply blood flow to the damaged area during peripheral arterial disease (PAD) revascularization. The surgeon’s preference and the patient’s condition determine which graft type is used. In this study, prosthetic and autogenous venous grafts in PAD are compared. \u0000University Heart Journal 2023; 19(2): 55-60","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"129 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141656457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Cardiac Troponin I Levels with the Severity of Coronary Artery Disease in Non-ST Elevation Myocardial Infarction 心肌肌钙蛋白 I 水平与非 STEV 心肌梗死冠状动脉疾病严重程度的关系
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73695
K. Mahmood, M. Arefin, M. M. Rahman, A. Jafar, Nishat Ahmed, Md Shafiqul Islam, M. Ahsan, Neena Islam, Forhad Karim Mojumder, M. Azam
Background : Among the acute coronary syndromes (ACS), Non-ST-elevation myocardial infarction (NSTEMI) is the most common presentation and a leading cause of hospital admissions. Prognosis of patients with ACS are related to the magnitude of cardiac biomarker release. Hence it is essential to see the relationship of increase in troponin levels in the setting of NSTEMI with the severity of CAD. Objective: This study was conducted to determine the association of cardiac troponin I (cTnI) with the severity of coronary artery disease in NSTEMI. Method : A cross-sectional analytical study was conducted on 120 NSTEMI patients admitted in National Institute of Cardiovascular Diseases, Dhaka between August 2016 to March 2017. cTnI was measured using IMMULITE 1000 (Siemens, USA) which is a three-step assay, based on the immunochemistry technology. All patients underwent coronary angiography in the index hospitalization. Stenosis > 70% in any of the three major epicardial vessels was considered significant CAD. Extent of CAD was defined as significant single, two or three vessel CAD. Chi-square test was applied to test the association between cTnI levels and CAD extent. Severity of coronary artery disease was also analysed by Vessel score and Gensini score. Spearmen’s Rank correlation test & Pearson’s correlation test were applied to test the association of cTnI with Vessel score and Gensini score respectively. Results: In the study, out of 120 patients, in 58 patients with cTnI levels < 10 folds upper limit of normal(ULN) (Group-I), (14) 24.1 % of the patients had single vessel, (18)31% had two vessel and (15)25.9 % had three vessel significant CAD, while among patients with cTnI levels > 10 folds ULN (Group-II) ,(11) 17.7 % of the patients had single vessel, (16)25.8% had two vessel and (29) 48.6% had three vessel significant CAD.There was an insignificant association between the cTnI levels and single vessel, two vessel CAD extent (p= 0.38, p= 0.52 respectively), however there was a statistically significant association between the cTnI levels and three vessel CAD (p=0.03) and also cTnI levels and multivessel disease (combined double vessel and triple vessel disease) (p=0.04). Mean vessel score was higher in group II than group I (2.101.02 vs. 1.641.07) with statistical significant difference (p=0.02). Mean Gensini Score was significantly higher in group II compared to group I (61.5±37.6 vs. 39.6±27.4, p<.001).There is a positive correlation between cTnI and coronary artery disease severity in terms of Gensini score (r=0.40, p=0.01).there is also a positive correlation between cTnI and coronary artery disease severity in terms of vessel score (r=0.28,p=0.01). Conclusion: Higher cTnI levels in NSTEMI are associated with severe CAD in the form of multi-vessel involvement with higher vessel score and Gensini score . Early coronary angiography should be considered especially in these patients & earlier revascularization would improve their clinical outcomes
背景:在急性冠状动脉综合征(ACS)中,非ST段抬高型心肌梗死(NSTEMI)是最常见的病症,也是入院治疗的主要原因。ACS 患者的预后与心脏生物标志物的释放量有关。因此,了解 NSTEMI 时肌钙蛋白水平的升高与 CAD 严重程度的关系至关重要。研究目的本研究旨在确定心肌肌钙蛋白 I(cTnI)与 NSTEMI 中冠状动脉疾病严重程度的关系。方法:2016 年 8 月至 2017 年 3 月期间,对达卡国立心血管疾病研究所收治的 120 名 NSTEMI 患者进行了横断面分析研究。cTnI 采用 IMMULITE 1000(美国西门子公司)进行测量,这是一种基于免疫化学技术的三步检测法。所有患者均在住院期间接受了冠状动脉造影术。三条主要心外膜血管中任何一条的狭窄程度大于 70% 即为严重的心血管并发症。CAD的程度被定义为明显的单根、两根或三根血管CAD。采用卡方检验来检验 cTnI 水平与 CAD 范围之间的关系。冠状动脉疾病的严重程度也通过血管评分和 Gensini 评分进行分析。Spearmen's Rank correlation test 和 Pearson's correlation test 分别用于检验 cTnI 与 Vessel score 和 Gensini score 的相关性。结果:研究发现,在 120 名患者中,58 名 cTnI 水平低于正常上限 10 倍(ULN)的患者(I 组)中,(14) 24.1% 的患者有单支血管,(18) 31% 的患者有两支血管,(15) 25.9% 的患者有三支血管显著的 CAD,而在 cTnI 水平高于正常上限 10 倍(ULN)的患者(II 组)中,(11) 17.7% 的患者有单支血管,(16) 25.8% 的患者有两支血管,(29) 48.6% 的患者有三支血管显著的 CAD。cTnI 水平与单血管、双血管 CAD 病变程度之间的关系不明显(分别为 p= 0.38、p= 0.52),但 cTnI 水平与三血管 CAD 病变之间的关系有统计学意义(p=0.03),cTnI 水平与多血管疾病(双血管和三血管疾病合并)之间的关系也有统计学意义(p=0.04)。第二组的平均血管评分高于第一组(2.101.02 对 1.641.07),差异有统计学意义(P=0.02)。就 Gensini 评分而言,cTnI 与冠状动脉疾病严重程度呈正相关(r=0.40,p=0.01);就血管评分而言,cTnI 与冠状动脉疾病严重程度也呈正相关(r=0.28,p=0.01)。结论在 NSTEMI 中,较高的 cTnI 水平与多血管受累、血管评分和 Gensini 评分较高的严重 CAD 相关。尤其是这些患者,应考虑尽早进行冠状动脉造影,尽早进行血管重建将改善他们的临床预后:37-44
{"title":"Association of Cardiac Troponin I Levels with the Severity of Coronary Artery Disease in Non-ST Elevation Myocardial Infarction","authors":"K. Mahmood, M. Arefin, M. M. Rahman, A. Jafar, Nishat Ahmed, Md Shafiqul Islam, M. Ahsan, Neena Islam, Forhad Karim Mojumder, M. Azam","doi":"10.3329/uhj.v3i1.73695","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73695","url":null,"abstract":"Background : Among the acute coronary syndromes (ACS), Non-ST-elevation myocardial infarction (NSTEMI) is the most common presentation and a leading cause of hospital admissions. Prognosis of patients with ACS are related to the magnitude of cardiac biomarker release. Hence it is essential to see the relationship of increase in troponin levels in the setting of NSTEMI with the severity of CAD. Objective: This study was conducted to determine the association of cardiac troponin I (cTnI) with the severity of coronary artery disease in NSTEMI. Method : A cross-sectional analytical study was conducted on 120 NSTEMI patients admitted in National Institute of Cardiovascular Diseases, Dhaka between August 2016 to March 2017. cTnI was measured using IMMULITE 1000 (Siemens, USA) which is a three-step assay, based on the immunochemistry technology. All patients underwent coronary angiography in the index hospitalization. Stenosis > 70% in any of the three major epicardial vessels was considered significant CAD. Extent of CAD was defined as significant single, two or three vessel CAD. Chi-square test was applied to test the association between cTnI levels and CAD extent. Severity of coronary artery disease was also analysed by Vessel score and Gensini score. Spearmen’s Rank correlation test & Pearson’s correlation test were applied to test the association of cTnI with Vessel score and Gensini score respectively. Results: In the study, out of 120 patients, in 58 patients with cTnI levels < 10 folds upper limit of normal(ULN) (Group-I), (14) 24.1 % of the patients had single vessel, (18)31% had two vessel and (15)25.9 % had three vessel significant CAD, while among patients with cTnI levels > 10 folds ULN (Group-II) ,(11) 17.7 % of the patients had single vessel, (16)25.8% had two vessel and (29) 48.6% had three vessel significant CAD.There was an insignificant association between the cTnI levels and single vessel, two vessel CAD extent (p= 0.38, p= 0.52 respectively), however there was a statistically significant association between the cTnI levels and three vessel CAD (p=0.03) and also cTnI levels and multivessel disease (combined double vessel and triple vessel disease) (p=0.04). Mean vessel score was higher in group II than group I (2.101.02 vs. 1.641.07) with statistical significant difference (p=0.02). Mean Gensini Score was significantly higher in group II compared to group I (61.5±37.6 vs. 39.6±27.4, p<.001).There is a positive correlation between cTnI and coronary artery disease severity in terms of Gensini score (r=0.40, p=0.01).there is also a positive correlation between cTnI and coronary artery disease severity in terms of vessel score (r=0.28,p=0.01). Conclusion: Higher cTnI levels in NSTEMI are associated with severe CAD in the form of multi-vessel involvement with higher vessel score and Gensini score . Early coronary angiography should be considered especially in these patients & earlier revascularization would improve their clinical outcomes","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"75 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141655330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally Invasive Ascending Aortic Replacement with Concomitant Aortic Valve Replacement, A Case Report 微创升主动脉置换术合并主动脉瓣置换术,病例报告
Pub Date : 2024-07-11 DOI: 10.3329/uhj.v3i1.73756
S. Gupta, Ali Haider, P. K. Chanda, D. K. Adhikary
Aortic valve stenosis or aortic stenosis is a type of heart valve disease (valvular heart disease). The valve between the lower left heart chamber and the body’s main artery (aorta) is narrowed and doesn’t open fully. This reduces or blocks blood flow from the heart to the aorta and to the rest of the body. Here we will discuss the care of a young male who presented with exertional dyspnea with palpitation and after detailed examination and investigation he was diagnosed as a care of severe aortic stenosis with moderate aortic regurgitation with bicuspid aortic valve and ascending aortic dilatation. University Heart Journal 2023; 19(2): 71-73
主动脉瓣狭窄或主动脉瓣狭窄是心脏瓣膜疾病(瓣膜性心脏病)的一种。左心室下部和人体主动脉(Aorta)之间的瓣膜变窄,不能完全打开。这就减少或阻断了从心脏流向主动脉和身体其他部位的血流。在此,我们将讨论一位年轻男性的护理,他因劳累性呼吸困难伴心悸而就诊,经过详细检查和调查,他被诊断为重度主动脉瓣狭窄伴中度主动脉瓣反流、主动脉瓣双瓣及升主动脉扩张。大学心脏杂志,2023;19(2):71-73
{"title":"Minimally Invasive Ascending Aortic Replacement with Concomitant Aortic Valve Replacement, A Case Report","authors":"S. Gupta, Ali Haider, P. K. Chanda, D. K. Adhikary","doi":"10.3329/uhj.v3i1.73756","DOIUrl":"https://doi.org/10.3329/uhj.v3i1.73756","url":null,"abstract":"Aortic valve stenosis or aortic stenosis is a type of heart valve disease (valvular heart disease). The valve between the lower left heart chamber and the body’s main artery (aorta) is narrowed and doesn’t open fully. This reduces or blocks blood flow from the heart to the aorta and to the rest of the body. Here we will discuss the care of a young male who presented with exertional dyspnea with palpitation and after detailed examination and investigation he was diagnosed as a care of severe aortic stenosis with moderate aortic regurgitation with bicuspid aortic valve and ascending aortic dilatation. \u0000University Heart Journal 2023; 19(2): 71-73","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"141 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141655979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Infective Endocarditis Caused by Rapidly Growing Non-tuberculous Mycobacterium after Cardiac Catheterization 心导管术后快速生长的非结核分枝杆菌引发的感染性心内膜炎病例
Pub Date : 2023-11-22 DOI: 10.3329/uhj.v19i1.69828
SM Nurul Huda, Mohammad Faisal Ibn Kabir, Md Fakhrul Islam Khaled, Afm Azim Anwar, Md Rasul Amin
Endocarditis caused by non-tuberculous mycobacterium is rare and often missed without appropriate blood cultures. It does not respond to standard antitubercular treatment and is also resistant to many other antibiotics. The course of the disease may be indolent and often results in a fatal outcome. Here we report a case of Nontuberculous mycobacterial endocarditis of the native aortic valve in an immunocompetent patient following coronary angiography. The case highlights an unfortunate intervention – related nosocomial infection and the difficulties in chemotherapeutic options for this organism, particularly in the presence of marrow suppression and acute interstitial nephritis. University Heart Journal 2023; 19(1): 31-34
由非结核分枝杆菌引起的心内膜炎非常罕见,如果没有适当的血液培养,往往会被漏诊。它对标准的抗结核治疗无效,对许多其他抗生素也有抗药性。该病的病程可能比较缓慢,但往往会导致死亡。在此,我们报告了一例免疫功能正常的患者在冠状动脉造影术后发生原位主动脉瓣非结核分枝杆菌性心内膜炎的病例。该病例突显了与介入治疗相关的一种不幸的院内感染,以及对这种病原体进行化疗的困难,尤其是在存在骨髓抑制和急性间质性肾炎的情况下。大学心脏杂志,2023;19(1):31-34
{"title":"A Case of Infective Endocarditis Caused by Rapidly Growing Non-tuberculous Mycobacterium after Cardiac Catheterization","authors":"SM Nurul Huda, Mohammad Faisal Ibn Kabir, Md Fakhrul Islam Khaled, Afm Azim Anwar, Md Rasul Amin","doi":"10.3329/uhj.v19i1.69828","DOIUrl":"https://doi.org/10.3329/uhj.v19i1.69828","url":null,"abstract":"Endocarditis caused by non-tuberculous mycobacterium is rare and often missed without appropriate blood cultures. It does not respond to standard antitubercular treatment and is also resistant to many other antibiotics. The course of the disease may be indolent and often results in a fatal outcome. Here we report a case of Nontuberculous mycobacterial endocarditis of the native aortic valve in an immunocompetent patient following coronary angiography. The case highlights an unfortunate intervention – related nosocomial infection and the difficulties in chemotherapeutic options for this organism, particularly in the presence of marrow suppression and acute interstitial nephritis. University Heart Journal 2023; 19(1): 31-34","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"8 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139249773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Angiographic Findings between Diabetic and nondiabetic Patients in Coronary Artery Disease: A Comparative Study 冠状动脉疾病中糖尿病患者与非糖尿病患者的冠状动脉造影结果:比较研究
Pub Date : 2023-11-22 DOI: 10.3329/uhj.v19i1.69782
Syed Mahabub Ebna Al Baker, Mohammad Nizamul Hossain Showdagor, Mukhlesur Rahman, Manzoor Mahmood, Ahsan Habib, Fazlur Rahman, Syed Ali Ahsan
Background & Objectives: Coronary artery disease (CAD) accounts for the major risk factor of mortality in diabetes. Coronary angiography is the “gold-standard” technique for diagnosing and evaluating CAD. Material and Methods: The present study was undertaken at Border Guard hospital, Dhaka between the periods of November - 2017 to December 2021. Percutaneous coronary angiography (CAG) was performed in 204 consecutive patients with suggestive of ischaemic chest pain. The population consisted of 88 cases which are diabetic and 116 cases nondiabetic Results: We observed angiographic lesion among both groups comparing site & number of vessel(s) involvement and also average percentage of stenosis. The presence of coronary risk factors was not significantly different between the two populations. Total positive angiographic lesion was (61.5%) in both groups. Among the Diabetes mellitus patients positive CAG finding (69.3%). The recognized lesions were single vessel disease (SVD) 23 (26.1%), double vessel disease (DVD) 14 (15.9%), triple vessel disease (TVD) 24 (27.3%) percentage of vessel stenosis 82.63%. On the other hand, total positive angiographic lesion was 70 (53.4%) in non-diabetic group; among them single vessel disease (SVD) 30 (25.9%), double vessel disease (DVD) 15(12.9%), triple vessel disease (TVD) 17 (14.7%). No diffuse lesions was found and average vessel stenosis was 78.03%. The results of the angiographic finding suggest that diabetic patients have a higher incidence of coronary heart disease (CHD), DVD, TVD, diffuse lesion & marked stenosis of coronary vessel than non-diabetic patient. Conclusion: CAD in diabetics had considerably higher percent of severe and unpredictable presentation. This increased frequency of complex lesion morphology is more difficult to treat by definitive intervention like percutaneous transluminal coronary angioplasty (PCI) & coronary artery bypass graft (CABG). Diabetics have a higher risk factor profile and poor clinical outcome. Early diagnosis and appropriate management will reduce the risk of complication after the onset of disease. University Heart Journal 2023; 19(1): 5-9
背景与目标:冠状动脉疾病(CAD)是糖尿病患者死亡的主要风险因素。冠状动脉造影术是诊断和评估 CAD 的 "金标准 "技术。材料和方法:本研究于 2017 年 11 月至 2021 年 12 月期间在达卡边防医院进行。对 204 名提示缺血性胸痛的连续患者进行了经皮冠状动脉造影术(CAG)。其中 88 例为糖尿病患者,116 例为非糖尿病患者:我们观察到两组患者的血管病变情况,比较了受累血管的部位和数量,以及血管狭窄的平均百分比。两组患者的冠状动脉危险因素无明显差异。两组的血管造影阳性病变总数均为(61.5%)。在糖尿病患者中,CAG 阳性率为 69.3%。公认的病变为单血管疾病(SVD)23 例(26.1%)、双血管疾病(DVD)14 例(15.9%)、三血管疾病(TVD)24 例(27.3%),血管狭窄率为 82.63%。另一方面,非糖尿病组血管造影阳性病变总数为 70(53.4%),其中单血管病变(SVD)30(25.9%),双血管病变(DVD)15(12.9%),三血管病变(TVD)17(14.7%)。未发现弥漫性病变,血管平均狭窄率为 78.03%。血管造影结果表明,与非糖尿病患者相比,糖尿病患者冠状动脉心脏病(CHD)、DVD、TVD、弥漫性病变和冠状动脉血管明显狭窄的发病率较高。结论糖尿病患者冠状动脉粥样硬化的严重程度和不可预知表现的比例要高得多。由于病变形态复杂,经皮冠状动脉腔内成形术(PCI)和冠状动脉旁路移植术(CABG)等明确的介入治疗更加困难。糖尿病患者的风险因素较高,临床预后较差。早期诊断和适当治疗可降低发病后并发症的风险。大学心脏杂志,2023;19(1):5-9
{"title":"Coronary Angiographic Findings between Diabetic and nondiabetic Patients in Coronary Artery Disease: A Comparative Study","authors":"Syed Mahabub Ebna Al Baker, Mohammad Nizamul Hossain Showdagor, Mukhlesur Rahman, Manzoor Mahmood, Ahsan Habib, Fazlur Rahman, Syed Ali Ahsan","doi":"10.3329/uhj.v19i1.69782","DOIUrl":"https://doi.org/10.3329/uhj.v19i1.69782","url":null,"abstract":"Background & Objectives: Coronary artery disease (CAD) accounts for the major risk factor of mortality in diabetes. Coronary angiography is the “gold-standard” technique for diagnosing and evaluating CAD. Material and Methods: The present study was undertaken at Border Guard hospital, Dhaka between the periods of November - 2017 to December 2021. Percutaneous coronary angiography (CAG) was performed in 204 consecutive patients with suggestive of ischaemic chest pain. The population consisted of 88 cases which are diabetic and 116 cases nondiabetic Results: We observed angiographic lesion among both groups comparing site & number of vessel(s) involvement and also average percentage of stenosis. The presence of coronary risk factors was not significantly different between the two populations. Total positive angiographic lesion was (61.5%) in both groups. Among the Diabetes mellitus patients positive CAG finding (69.3%). The recognized lesions were single vessel disease (SVD) 23 (26.1%), double vessel disease (DVD) 14 (15.9%), triple vessel disease (TVD) 24 (27.3%) percentage of vessel stenosis 82.63%. On the other hand, total positive angiographic lesion was 70 (53.4%) in non-diabetic group; among them single vessel disease (SVD) 30 (25.9%), double vessel disease (DVD) 15(12.9%), triple vessel disease (TVD) 17 (14.7%). No diffuse lesions was found and average vessel stenosis was 78.03%. The results of the angiographic finding suggest that diabetic patients have a higher incidence of coronary heart disease (CHD), DVD, TVD, diffuse lesion & marked stenosis of coronary vessel than non-diabetic patient. Conclusion: CAD in diabetics had considerably higher percent of severe and unpredictable presentation. This increased frequency of complex lesion morphology is more difficult to treat by definitive intervention like percutaneous transluminal coronary angioplasty (PCI) & coronary artery bypass graft (CABG). Diabetics have a higher risk factor profile and poor clinical outcome. Early diagnosis and appropriate management will reduce the risk of complication after the onset of disease. University Heart Journal 2023; 19(1): 5-9","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"54 4-5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139248007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
University Heart Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1